Emergency Department Screening Program Can ID Undiagnosed Prediabetes, T2DM

Only 25.0 percent of patients who were identified self-reported having been diagnosed with prediabetes or type 2 diabetes

a blood tubes
Adobe Stock

THURSDAY, Jan. 26, 2023 (HealthDay News) -- An emergency department type 2 diabetes (T2D) screening program can identify patients with undiagnosed prediabetes and diabetes, according to a research letter published online Jan. 26 in JAMA Network Open.

Kirstie K. Danielson, Ph.D., from the University of Illinois Chicago, and colleagues developed and piloted an emergency department T2D screening program. Patients at risk for T2D were flagged with a best practice alert (BPA), which was built into the electronic medical record. If blood was drawn, the clinician had the option to add hemoglobin A1c (HbA1c) measurement. Patients were called to provide results and inquire about prior awareness and treatment of diabetes.

Overall, 8,441 patients visited the emergency department during the pilot study; the BPA triggered tests for 2,576 patients and an HbA1c result was available for 2,074 of these. A total of 1,085 patients with an HbA1c result (52.3 percent) had an abnormal reading: 69.9 and 30.1 percent had prediabetes and diabetes, respectively. A total of 352 patients were contacted by telephone and constituted the study sample. The researchers found that 50.0 percent of the patients had public insurance and 4.0 percent were uninsured. Overall, 25.0 percent of the patients self-reported that they had been diagnosed with prediabetes or T2D; only 58.0 percent of these reported receiving treatment.

"Our emergency department screening program identified a substantial number of patients with undiagnosed prediabetes and T2D or undermanaged disease, particularly racial and ethnic minority individuals and low-income patients," the authors write.

Several authors disclosed financial ties to Novo Nordisk A/S, which funded the study.

Abstract/Full Text

Elana Gotkine

Elana Gotkine

Medically reviewed by Mark Arredondo, M.D.

Published on January 26, 2023

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ